Peripheral Blood Mononuclear Cells Market to Grow with a CAGR of 9.38% through 2027
Increased number of cell therapies for human well-being and growing use of PBMCs in toxicology research during the forecast period. According to TechSci Research report, “Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2017-2027 ” , the Global Peripheral Blood Mononuclear Cells market stood at USD 216.52 million in 2021 and is anticipated to grow with a CAGR of 9.38% in the forecast period, 2022-2027. The major factors driving the growth of Peripheral Blood Mononuclear Cells Market include increase in number of cell therapies, growing R&D of Peripheral Blood Mononuclear Cells and growing usage of peripheral cells in toxicology research. The peripheral blood mononuclear cells (PBMCs) are used to investigate the effect of food bio-actives on various immune cells. They have a round nucleus, consists of macrophages, dendritic cells, monocytes, and lymphocytes (T cells, B cells, and NK cells...